ClinicalTrials.gov record
Enrolling by invitation Phase 3 Interventional

Clinical Trial of Vormatrigine in Adult Patients With Epilepsy

ClinicalTrials.gov ID: NCT07287163

Public ClinicalTrials.gov record NCT07287163. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 6:21 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Open Label Extension Clinical Trial of Vormatrigine in Adult Patients With Epilepsy

Study identification

NCT ID
NCT07287163
Recruitment status
Enrolling by invitation
Study type
Interventional
Phase
Phase 3
Lead sponsor
Praxis Precision Medicines
Industry
Enrollment
700 participants

Conditions and interventions

Interventions

  • vormatrogine Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 26, 2025
Primary completion
May 30, 2028
Completion
Dec 30, 2028
Last update posted
Dec 16, 2025

2025 – 2028

United States locations

U.S. sites
9
U.S. states
6
U.S. cities
9
Facility City State ZIP Site status
Praxis Research Site Miami Lakes Florida 33016
Praxis Research Site Naples Florida 34116
Praxis Research Site Lafayette Louisiana 70508
Praxis Research Site Bethesda Maryland 20817
Praxis Research Site Chesterfield Missouri 63005
Praxis Research Site Amherst New York 14226
Praxis Research Site Middletown New York 10941
Praxis Research Site El Paso Texas 79912
Praxis Research Site Houston Texas 77058

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07287163, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 16, 2025 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07287163 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →